Hospital groups sue HHS seeking 340B price transparency

September 11, 2018: The AHA, Association of American Medical Colleges, America’s Essential Hospitals, 340B Health and three hospital systems today asked a federal court to order the Department of Health and Human Services to make effective within 30 days a final rule requiring drug companies to disclose the ceiling price for 340B outpatient drugs. Required by Congress in 2010, HHS has delayed the rule’s effective date five times. To ensure accuracy and compliance with the 340B drug savings program, the rule also describes how ceiling prices must be calculated and would allow the federal government to levy civil monetary penalties against drug companies that intentionally overcharge 340B providers.


Complaint

Motion for Summary Judgment

Memorandum in Support of Motion

Related Resources

Action Alert
Member
The Senate Committee on Health, Education, Labor and Pensions has released the Lower Health Care Costs Act of 2019 – bipartisan discussion draft legislation to…
Press Releases
Public
Legal Documents
Public
Legal Documents
Public
Fact Sheets
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Press Releases
The AHA is pleased that, in response to our successful lawsuit, the Health Resources and Services Administration today launched a new website to shine needed…